期刊文献+

安非他酮联合丙戊酸镁治疗双相抑郁的对照研究

下载PDF
导出
摘要 双相情感障碍抑郁发作又称"双相抑郁",对这类患者的治疗争议很多[1-4]。治疗指南在针对双相抑郁的治疗时,强调心境稳定剂的使用。但单一心境稳定剂治疗双相抑郁可能起效比较慢或效果不佳,因此,心境稳定剂联合抗抑郁药或联合非典型抗精神病药是常规的治疗选择[5-6]。使用抗抑郁剂是否可以提高疗效、增加转躁的风险,也有不同的报道。
出处 《中国初级卫生保健》 2013年第9期126-127,共2页 Chinese Primary Health Care
  • 引文网络
  • 相关文献

参考文献13

  • 1Frye M A, HellemanG, McElroy S L, et al. Correlates of treat- mentemergent mania associated with antidepressant treatment inbipolar depression[J]. Am J Psychiatry, 2009, 166(2) : 164-172.
  • 2Hausmann A, Hlrtnagl C, WalpothM, et al. Are there substantial reasons for contraindicating antidepressants inbipolar disorder part II: factsor ar-tefacts[J]. Neuropsychiatr, 2007, 21(2): 131-158.
  • 3赵靖平,司天梅.精神病学[M].北京:人民卫生出版社,2009:583.
  • 4Thase M E. Pharmacotherapy of bipolar depression: anupdate[J]. Curr Psychiatry Rep, 2006, 8(6): 478-488.
  • 5Young L T, Joffe R T, Robb J C, et al. Double blind comparison of addition of a second mood stabilizer versus an antidepressants toan initial mood stabilizer for treatment of patients with bipolar depression[J]. Am J Psychiatry, 2000(157) : 124-126.
  • 6Ghaemi S N, Gilmer W S, Goldberg J F, et al. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study[J]. Clin Psychiatry, 2007 (68) : 1840-1844.
  • 7ClaytonAH. Extended release bupropion: anant-idepressant with abroad spectrum of the rapeutie activity[J]. Expert Opin Pharma- tother, 2007, 8(4): 457-466.
  • 8沈一峰,李华芳,孙学礼,许秀峰,高成阁,顾牛范.安非他酮缓释片治疗抑郁症的随机双盲多中心临床试验[J].中国临床药学杂志,2008,17(3):136-140. 被引量:5
  • 9Lam R W, Hossie H, Solomons K, et al. Citalo-pramandbupmpion- SR: conbining versus switching in patients with treatment resistant depression[J]. JClinPsychiatry, 2004, 65(3): 337-340.
  • 10Glod CA, Lynch A, Flynn E, et al. Open trial of bupropion SR in adolescent major depression[J]. Child Adolesc Psychiatr Nuts, 2003, 16(3): 123-130.

二级参考文献29

  • 1李华芳,赵靖平,况伟宏,姚培芬,陈晋东,孙学礼,顾牛范.安非他酮缓释片治疗抑郁症72例的随机双盲双模拟多中心临床研究[J].中国新药与临床杂志,2005,24(8):614-618. 被引量:14
  • 2Tomarken A J, Dichter GS, Freid C, et al. Assessing the effects of bupropion SR on mood dimensions of depression[J]. J Affect Disord, 2004, 78(3): 235.
  • 3Glod CA, Lynch A, Flynn E, et al. Open trial of buprepion SR in adolescent major depression[J]. J Child Adolesc Psychiatr Nuts, 2003, 16 (3): 123.
  • 4Jamerson BD, Krishnan KR, Roberts J, et al. Effect of bupropion SR on specific symptom clusters of depression: analysis tithe 31 - item Hamilton Rating Scale for depression [ J ]. Psychopharmacol Bull, 2003, 37 (2) : 67.
  • 5Croft H, Houser TL, Jamerson BD, et al. Effect on body weight of bupropion sustained - release in patients with major depression treated for 52 weeks[J]. Clin Ther, 2002, 24(4): 662.
  • 6Weihs KL, Honser TL, Batey SR, et al. Continuation phase treatment with buprepion SR effectivdy decreases the risk for relapse of depression [J]. Bid Psychiatry, 2002, 51 (9): 753.
  • 7Nieuwstraten CE, Dolovich LR. Buprepion versus selective serotonin-reuptake inhibitors for treatment of depression[J]. Ann Pharmacother, 2001, 35(12): 1608.
  • 8Settle EC, Stahl SM, Batey SR, et al. Safety profile of sustained-release buprepion in depression: results of three clinical trials[J]. Clin Ther, 1999, 21(3): 454.
  • 9Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication [ J]. Arch Gen Psychiatry,, 2005,62(6) :617 - 627.
  • 10Rush A J, Fava M, Wisniewski SR, et al. Sequenced treatment ahematives to relieve depression (STAR * D): rationale and design [ J ]. Control Clin Trials, 2004, 25 (1):119- 142.

共引文献16

;
使用帮助 返回顶部